NBC4 New York, August 31, 2016. The CEO of Mylan Pharmaceuticals announced the launch of its own cheaper version of the EpiPen but previously fought to keep prices high by limiting options.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Part D Pricing Trends
POLITICO Prescription Pulse, August 22, 2016. Medtronic is facing allegations that it promoted a device for uses not approved by FDA. “If the device had been tested in a clinical trial it would have been clear that it was designed to fit a part of the spine the company wasn’t seeking approval for,” Diana Zuckerman of the National Center for Health Research explained to STAT.
Read More »PDUFA Again: Still Trying to Get It Right
MedPage Today, August 20, 2016: The Pharmaceutical Industry and some patient groups praised the latest drug user fee plan (PDUFA), but consumer advocates warned that drug safety is compromised when the focus is on faster approvals.
Read More »Ask the Expert: Is It Okay to Let My Toddler Use My iPad for Nursery Rhymes?
Irish Independent, August 17, 2016: You should not buy an iPad tablet for your toddler, because toddlers exposed to more screen time are more likely to face delays in learning, have poor sleep, develop behavior problems, and have weaker parent-child interactions. The article recommends the article on National Center for Health Research’s website.
Read More »Whistleblower Case Contends Surgical Device Maker Misled FDA — and Patients Paid the Price
STAT, August 15, 2016. Medtronic now faces a whistleblower lawsuit that claims it sought FDA approval for its devices under false pretenses. More scrutiny in a trial would have made it clear that the Medtronic device was sized to fit in the neck.
Read More »